ArticleHuman cell2024
Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor.
Keisuke Kato et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it